Spero Therapeutics Inc (SPRO) Down 2.31% in Premarket Trading

Tuesday, March 19, 2024 07:28 AM | InvestorsObserver Analysts

Mentioned in this article

Spero Therapeutics Inc (SPRO) is lower by Tuesday morning, with the stock losing -2.31% in pre-market trading to 1.69. SPRO's short-term technical score of 84 indicates that the stock has traded more bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 98 out of 146 industries, the stock ranks higher than 92% of stocks. Spero Therapeutics Inc has risen 13.07% over the past month, closing at $1.53 on February 20. During this period of time, the stock fell as low as $1.47 and as high as $1.89. SPRO has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.

SPRO has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on SPRO!
Spero Therapeutics Inc has a Long-Term Technical rank of 78. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 22% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, SPRO ranks better than 74% of stocks.

Important Dates for Investors in SPRO:

-Spero Therapeutics Inc is set to release earnings on 2024-05-09. Over the last 12 months, the company has reported EPS of $0.39. -We do not have a set dividend date for Spero Therapeutics Inc at this time. Click Here To Get The Full Report on Spero Therapeutics Inc (SPRO)

Share this article: